Newstral
Roger Perlmutter
- Eikon Therapeutics strikes lease deal to shift headquarters to MillbraeSan Jose Mercury News
- This Startup Raised Over $500 Million To Find Better Drugs With Nobel Prize-Winning MicroscopesForbes
- Merck CEO Kenneth Frazier to retire at the end of JuneNew York Post
- BMerck Scraps Covid-19 Vaccine Programsbarrons.com
- MU.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infectionsmarketwatch.com
- Merck’s R&D Chief to Retirewsj.com
- Big Pharma chief who developed first Ebola shot breaks silence on COVID-19Sydney Morning Herald
- BMerck CEO Warns of a Longer Wait for a Covid-19 Vaccinebarrons.com
- MCoronavirus update: Global case tally crosses 5.5 million as WHO warns of risk of ‘second peak’ in current infection wavemarketwatch.com
- Merck announces work on coronavirus vaccine, says clinical trials may start later this yearnj.com
- Merck Jumps Into The Race For A Coronavirus VaccineForbes
- MCoronavirus update: Optimism over phased reopenings is tempered by continued concerns over inadequate testing for COVID-19 virusmarketwatch.com
- MShares of Merck gain on COVID-19 research collaborationmarketwatch.com
- Seattle biotech’s shares quadruple on news of buyout by MerckSeattle Times
- Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So HardForbes
- Biotech Firm Incyte Finds The Right Chemistry For SuccessForbes
- What You Should Know About Ken Frazier, The CEO Who Just Quit A Trump Advisory CouncilForbes
- HA Strong 2Q for Merck, Outlook Mixedhamodia.com
- The Startling History Behind Merck's New Cancer BlockbusterForbes
- Promising Alzheimer's drug fails trialCNN
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.